tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SCYX Stock Latest News

Scynexis price target lowered to $3 from $4 at Guggenheim
The FlyScynexis price target lowered to $3 from $4 at Guggenheim
3d ago
GSK
SCYX
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
PremiumRatings
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
15d ago
SCYX
SCYNEXIS and GSK Amend License Agreement
PremiumCompany Announcements
SCYNEXIS and GSK Amend License Agreement
16d ago
8K
SCYX
Scynexis, GSK resolve disagreement related to restart of Phase 3 MARIO study
PremiumThe Fly
Scynexis, GSK resolve disagreement related to restart of Phase 3 MARIO study
16d ago
SCYX
Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility
PremiumRatings
Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility
30d ago
SCYX
Scynexis announces results from Phase 1 SAD/MAD study of SCY-247
PremiumThe FlyScynexis announces results from Phase 1 SAD/MAD study of SCY-247
1M ago
SCYX
Promising Potential of SCY-247: A Game-Changer in Antifungal Treatment
Premium
Ratings
Promising Potential of SCY-247: A Game-Changer in Antifungal Treatment
2M ago
SCYX
Scynexis announces presentations highlighting data on SCY-247
Premium
The Fly
Scynexis announces presentations highlighting data on SCY-247
2M ago
SCYX
Optimistic Outlook on SCYNEXIS: Strategic Developments and Financial Health Drive Buy Rating
PremiumRatings
Optimistic Outlook on SCYNEXIS: Strategic Developments and Financial Health Drive Buy Rating
3M ago
SCYX
SCYNEXIS Reports Improved Financials Amidst Strategic Developments
PremiumCompany Announcements
SCYNEXIS Reports Improved Financials Amidst Strategic Developments
3M ago
SCYX
Scynexis reports Q2 EPS (14c), consensus (19c)
PremiumThe Fly
Scynexis reports Q2 EPS (14c), consensus (19c)
3M ago
SCYX
SCYNEXIS Inc. Advances Phase 3 Study for Invasive Candidiasis Treatment
PremiumCompany Announcements
SCYNEXIS Inc. Advances Phase 3 Study for Invasive Candidiasis Treatment
3M ago
SCYX
SCYNEXIS Inc. Advances Antifungal Treatment with Phase 3 Study
PremiumCompany AnnouncementsSCYNEXIS Inc. Advances Antifungal Treatment with Phase 3 Study
3M ago
SCYX
SCYNEXIS Holds Annual Meeting, Re-elects Directors
Premium
Company Announcements
SCYNEXIS Holds Annual Meeting, Re-elects Directors
4M ago
8K
SCYX
SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price
Premium
Company Announcements
SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price
4M ago
8K
SCYX
SCYNEXIS: Positive Developments and Financial Stability Justify Buy Rating
PremiumRatings
SCYNEXIS: Positive Developments and Financial Stability Justify Buy Rating
5M ago
SCYX
Scynexis resumes patient dosing in Phase 3 MARIO study
PremiumThe Fly
Scynexis resumes patient dosing in Phase 3 MARIO study
5M ago
GSK
SCYX
SCYNEXIS: Buy Rating Affirmed Amid Strategic Advancements and Promising Antifungal Innovations
PremiumRatings
SCYNEXIS: Buy Rating Affirmed Amid Strategic Advancements and Promising Antifungal Innovations
5M ago
SCYX
SCYNEXIS Faces Challenges Amidst Antifungal Developments
PremiumCompany Announcements
SCYNEXIS Faces Challenges Amidst Antifungal Developments
5M ago
SCYX
Scynexis reports Q1 EPS (11c), consensus (19c)
PremiumThe FlyScynexis reports Q1 EPS (11c), consensus (19c)
6M ago
SCYX
Scynexis expects cash to fund operations into Q3 of 2026
Premium
The Fly
Scynexis expects cash to fund operations into Q3 of 2026
6M ago
SCYX
SCYX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SCYX Earnings this Week: How Will it Perform?
6M ago
SCYX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >